Publications |https://gbnegrinicv.netlify.app/publications/PublicationsHugoBlox Kit (https://hugoblox.com)en-ushttps://gbnegrinicv.netlify.app/media/icon.svgPublicationshttps://gbnegrinicv.netlify.app/publications/Attention-deficit/hyperactivity disorder polygenic risk score and incidence of cognitive impairment in older adults: A prospective multicohort studyhttps://gbnegrinicv.netlify.app/publications/leffa-bauer-negrini-adhd-prs-cognitive-2026/Sat, 01 Aug 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/leffa-bauer-negrini-adhd-prs-cognitive-2026/Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant studyhttps://gbnegrinicv.netlify.app/publications/povala-head-lancet-2026/Sat, 30 May 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-head-lancet-2026/Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trialshttps://gbnegrinicv.netlify.app/publications/ferreira-evaluating-2026/Tue, 13 Jan 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/ferreira-evaluating-2026/Low-dose CT for MRI-free quantification of tau PET in Alzheimer's disease: a multicentre, cross-sectional, comparison studyhttps://gbnegrinicv.netlify.app/publications/povala-ct-lanmit-2026/Thu, 01 Jan 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-ct-lanmit-2026/In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuumhttps://gbnegrinicv.netlify.app/publications/leffa-vivo-measured-2025/Sun, 14 Dec 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/leffa-vivo-measured-2025/CSF total tau as a proxy of synaptic degenerationhttps://gbnegrinicv.netlify.app/publications/soares-csf-2025/Fri, 29 Aug 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/soares-csf-2025/Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/abbas-utility-2025/Fri, 01 Aug 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/abbas-utility-2025/Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/rohden-glial-2025/Tue, 01 Jul 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/rohden-glial-2025/Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/bellaver-plasma-2025/Thu, 01 May 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bellaver-plasma-2025/Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/leffa-impact-2025/Sat, 01 Feb 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/leffa-impact-2025/Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegenerationhttps://gbnegrinicv.netlify.app/publications/povala-amyloid-2025/Wed, 01 Jan 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-amyloid-2025/Classification of Autism Spectrum Disorder Using a 3D-CNN Ensemble Model and Regional Homogeneity Data from the ABIDE I Datasethttps://gbnegrinicv.netlify.app/publications/bauer-negrini-classification-2024/Mon, 01 Jan 2024 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bauer-negrini-classification-2024/A comprehensive bioinformatics analysis of circRNA expression in the brain of distinct mouse models of Autism Spectrum Disorderhttps://gbnegrinicv.netlify.app/publications/bauer-negrini-comprehensive-2023/Wed, 01 Nov 2023 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bauer-negrini-comprehensive-2023/Usability evaluation of circRNA identification tools: Development of a heuristic-based framework and analysishttps://gbnegrinicv.netlify.app/publications/bauer-negrini-usability-2022/Mon, 01 Aug 2022 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bauer-negrini-usability-2022/The role of T-cells in neurobehavioural development: Insights from the immunodeficient nude micehttps://gbnegrinicv.netlify.app/publications/bauer-negrini-role-2022/Thu, 10 Feb 2022 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bauer-negrini-role-2022/Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autismhttps://gbnegrinicv.netlify.app/publications/santos-terra-resveratrol-2022/Sat, 01 Jan 2022 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/santos-terra-resveratrol-2022/Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal modelhttps://gbnegrinicv.netlify.app/publications/deckmann-resveratrol-2021/Fri, 01 Jan 2021 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/deckmann-resveratrol-2021/Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autismhttps://gbnegrinicv.netlify.app/publications/hirsch-effects-2020/Fri, 01 May 2020 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/hirsch-effects-2020/Abnormal empathy-like pro-social behaviour in the valproic acid model of autism spectrum disorderhttps://gbnegrinicv.netlify.app/publications/fontes-dutra-abnormal-2019/Fri, 17 May 2019 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/fontes-dutra-abnormal-2019/Reduced CD4 T Lymphocytes in Lymph Nodes of the Mouse Model of Autism Induced by Valproic Acidhttps://gbnegrinicv.netlify.app/publications/baronio-reduced-2018/Fri, 17 Aug 2018 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/baronio-reduced-2018/Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acidhttps://gbnegrinicv.netlify.app/publications/fontes-dutra-resveratrol-2018/Tue, 22 May 2018 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/fontes-dutra-resveratrol-2018/Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNAhttps://gbnegrinicv.netlify.app/publications/hirsch-behavioral-2018/Tue, 01 May 2018 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/hirsch-behavioral-2018/